Regulations.gov document
"Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of…
Notice · FDA-1997-D-0008 · posted Jan 18, 2002
Key facts
| Document ID | FDA-1997-D-0008-0001 |
|---|---|
| Title | "Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products;" Availability |
| Document type | Notice |
| Subtype | Notice of Data Availability |
| Agency | FDA |
| Docket | FDA-1997-D-0008 |
| Posted | Jan 18, 2002 |
| Federal Register citation | 67 FR 2226 |
| FR document number | 02-1026 |
| Effective date | Jan 7, 2002 |
At a glance
- 1–9 Pages
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: